# BriaCell Therapeutics Corp.: Form 8-K, filed Feb 15, 2023

- Company: [BriaCell Therapeutics Corp.](/companies/bctx.md) (CIK 1610820)
- Form: 8-K
- Filed: 2023-02-15
- Accepted by EDGAR: Feb 15, 2023, 16:00 ET
- Period: 2023-02-09
- Accession: 0001493152-23-005199
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1610820/000149315223005199/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1610820/000149315223005199/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1610820/000149315223005199/form8-k.htm

Filed Feb 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-005199. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
